Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
State Policy
California Enacts Legislation on Reporting of Prescription Drug Costs
California’s Senate and Assembly have both passed legislation on publishing prescription drug prices (SB-17) and presented the…
Taking Center Stage – Washington State’s Medicaid Fraud Control Unit,…
On July 26, 2017, the Washington State Attorney General (“AG”) Bob Ferguson (“Ferguson”) announced one of the State’s largest…
Draft Released on Nevada Pharmaceutical Representative Registration…
Nevada passed legislation earlier this year, putting many new restrictions and regulations on the pharmaceutical industry there.…
PhRMA and Bio Sue Nevada
On September 2, 2017, Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization…
Ohio Drug Distribution Verification: America’s Key Battleground State…
The pharmaceutical industry faces monumental challenges in the age of globalization within the United States: state laws and…
Louisiana Price Transparency Measures Go into Effect…With An Interesting…
According to LexisNexis State Net, during 2017, about half of the states and Congress collectively introduced almost 90 measures…
New Jersey Governor Christie Introduces Regulation to Cap Physician-Pharma…
In the last days of his administration, New Jersey Governor Chris Christie has introduced a regulation to cap the amount…
Chicago Proposes Drug Pricing Transparency Ordinance
Chicago Alderman Edward M. Burke recently held a hearing on the proposed city ordinance, “Chicago Drug Pricing Transparency…
A Murky Future for Off-label Promotion: States vs. FDA – Arizona to…
Arizona was the first state to bite the bullet and allow pharmaceutical companies to communicate off-label uses of their drugs to…
Ohio “Drug Price Relief Act” Ballot Update
We have previously written about the ballot proposition that is scheduled to be on the ballot in Ohio this November as Issue #2.…